In light of COVID-19, we would like to reassure you that our business will continue with minimal disruption.
As an ISO accredited biotech business in the medical science sector, we have always operated with stringent risk management protocols and contingency plans.
As a result we have various measures in place to ensure the safety of our people and products during this declared national state of disaster, and that business continuity is assured.
Our Client Services Team are readily available to assist you should you have any queries- they can be contacted via phone, email and WhatsApp.
Netcells- 084 664 4646,
Next Genetics- 082 386 5289,
Placelta- 011 697 2907,
Information from the SA government on COVID-19: